ChemicalBook > Product Catalog >API >Circulatory system drugs >Lipid regulating drugs >Atorvastatin

Atorvastatin

Atorvastatin Structure
CAS No.
134523-00-5
Chemical Name:
Atorvastatin
Synonyms
ATORVASTATIN CA;Atorvastatin (Subject to Patent free);ATORVASTATIN CALCIUM SALT;Atorvastatin acid;ATORVASTATIN DIPROTECTED;Atorvastatin CalciuM Tablets;(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid;Cardyl;025-83371857;Atrovastitne
CBNumber:
CB4239912
Molecular Formula:
C33H35FN2O5
Molecular Weight:
558.65
MOL File:
134523-00-5.mol
MSDS File:
SDS
Modify Date:
2024/8/2 18:12:07

Atorvastatin Properties

Melting point 176-178°C
Boiling point 722.2±60.0 °C(Predicted)
Density 1.23±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: 100 mg/mL (179.01 mM)
pka pKa 4.46(H2O t=30 Iuncontrolled) (Uncertain)
form Solid
color White to light yellow
CAS DataBase Reference 134523-00-5(CAS DataBase Reference)
EPA Substance Registry System 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (?R,?R)- (134523-00-5)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS03,GHS07
Signal word  Warning
Hazard statements  H272-H315-H319-H335
Precautionary statements  P221-P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P370+P378r-P370+P380+P375-P380-P501c
Hazard Codes  Xn
Risk Statements  20/21/22-36/37/38
Safety Statements  26-36
HS Code  35040000

Atorvastatin Chemical Properties,Uses,Production

Chemical Properties

white Crystalline powder

Uses

antihyperlipoproteimic;HMG-CoA reductase inhibition

General Description

Atorvastatin, [R-(R*,R*)]-2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lH-pyrrole-1-heptanoic acid(Lipitor), also possesses the heptanoic acid side chain,which is critical for inhibition of HMG-CoA reductase.Although the side chain is less lipophilic than the lactoneform, the high amount of lipophilic substitution causes this agent to have a slightly higher level of CNS penetration thanpravastatin, resulting in a slight increase in CNS side effects.Even so, its CNS profile is much lower than that of lovastatin.Atorvastatin is marketed as a combination therapywith amlodipine under the trade name Norvasc for managementof high cholesterol and high blood pressure.

Atorvastatin Preparation Products And Raw materials

Global( 283)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CHEMXTREE STANDARDS +919872732255 Punjab, India 96 58 Inquiry
OPULENT PHARMA +91-9106692785 +91-9106692785 Gujarat, India 479 58 Inquiry
Anant Pharmaceuticals Pvt Ltd +91-8550986868 +91-9485998001 Haryana, India 461 58 Inquiry
Vadivarhe Speciality Chemicals Limited +91-9028832204 +91-9028832204 Maharashtra, India 38 58 Inquiry
GLP Pharma Standards +91 9866074638 Hyderabad, India 1644 58 Inquiry
Evans Fine Chem +91-9821340302 +91-9821340302 Maharashtra, India 286 58 Inquiry
Shree HariKrishna Pharmaceuticals +91-9925611910 +91-9925611910 Gujarat, India 16 58 Inquiry
Sainor Life Sciences Pvt Ltd +919542990009 AndhraPradesh, India 13 58 Inquiry
Svak Life Sciences +91-9963463333 +91-9705383777 Hyderabad, India 101 58 Inquiry
Dayaram Pharma Chem +91-9601766800 +91-9601766800 Gujarat, India 61 58 Inquiry

Atorvastatin Spectrum

Atorvastatin&Ats-5Ats-8Ats-9M4L1 Atrovastitne (bR,dR)-2-(p-Fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, [R-(R*,R*)]- Cardyl [R-(R^<*>^,R^<*>^)]-2-(4-Fluorophenyl)- β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylarnino)carbonyl]-1H.Pyrrole-1- heptanoic acid (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-enanthic acid (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbaMoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid 025-83371857 (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbaMoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydr (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dih ATORVASTATIN (3R,5R)-2-(4-Fluorophenyl)-3,5-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid Atorvastatin free ACID Atorvastatin USP/EP/BP Atorvastatin DISCONTINUED See A791750 or A791730 Atorvastatin acid Atorvastatin CalciuM Tablets ATORVASTATIN DIPROTECTED Atorvastatin (Subject to Patent free) (3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid ATORVASTATIN CA ATORVASTATIN CALCIUM SALT Atorvastatin calcium salt Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3- phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]- 3,5dihydroxyheptanoate (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid 134523-00-5 134523-03-0 C33H34FN2O53H2O C33H35FN2O5 C33H33CaFNO5